Cargando…
Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer
Lung cancer is the deadliest cancer in the world. Angiogenesis plays a crucial role of the incidence, progression, and metastasis in lung cancer. Angiogenesis inhibitors are used to treat non-small cell lung cancer (NSCLC) patients, and the molecular biomarkers are also being assessed to predict tre...
Autores principales: | Guo, Sumin, Martin, Michael G., Tian, Cheng, Cui, Jinglin, Wang, Lishi, Wu, Shucai, Gu, Weikuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907677/ https://www.ncbi.nlm.nih.gov/pubmed/29675110 http://dx.doi.org/10.7150/jca.22020 |
Ejemplares similares
-
The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023) -
Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis
por: Jiao, Yan, et al.
Publicado: (2015) -
Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization
por: Wu, Hong, et al.
Publicado: (2022) -
Sex Difference of Egfr Expression and Molecular Pathway in the Liver: Impact on Drug Design and Cancer Treatments?
por: Wang, Lishi, et al.
Publicado: (2016) -
Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation
por: Cameron, Alan C., et al.
Publicado: (2020)